Prolapsing inflammatory myofibroblastic tumor of the urinary bladder: A case report and a review of literature

Higazy, Ahmed; Kandel, Mohamed

doi:10.1016/j.eucr.2020.101191

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although it occurs most commonly in the lungs, 2 extra pulmonary presentation of PCG was reported to affect other organs such as the vagina, bladder, and the abdominal cavity. 3 The occurrence of PCG in the head and neck region is also rare. Oral plasma cell granuloma has been reported to be rarely seen in the oral cavity, as a single unilateral swelling seen primarily on the periodontal tissue, mainly the gingiva, 4 followed by the tongue, 5 lips, 6 buccal and oral mucosa.…”

Section: Introductionmentioning

confidence: 99%

Clinicopathological Study of Oral Plasma Cell Granuloma

Zaki¹,

El-sissy²,

Ibrahim³

2022

Mansoura Journal of Dentistry

View full text Add to dashboard Cite

Objective: To identify the characteristic clinical and Histopathologic features encountered in the oral lesions of PCG; thus clarifying the variability nature of the studied oral plasma cell granulomas (OPCGS). Materials and Methods: A sample of 25 retrospective paraffin blocks of OPCGS was thoroughly investigated histopathologically. Results: the studied OPCG was mainly represented as a gingival swelling, there was a female tendency in most of the studied OPCGS (92%), ranging from 11-73 years with a mean of 42.40. the majority of the current OPCG (64%) did not express any bone changes. the OPCGS of the present work were characterized by their variable histopathological features, thus creating a marked histological diversity Conclusions: Oral plasma cell granuloma (OPCG) is a benign inflammatory lesion that requires biopsy and Histopathological examination to be differentially diagnosed from other lesions irrespective of the clinical features and clinical diagnoses. this is important to rule out possible neoplastic and plasma cell dyscrasias, and other similar diseases such as multiple myeloma.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinicopathological Study of Oral Plasma Cell Granuloma

Zaki¹,

El-sissy²,

Ibrahim³

2022

Mansoura Journal of Dentistry

View full text Add to dashboard Cite

show abstract

A Conservative Approach to Inflammatory Myofibroblastic Tumor of the Bladder: A Case Report and Review of Literature

Zahr

Ghabi

Idrissi-Kaitouni

et al. 2021

Case Reports in Urology

View full text Add to dashboard Cite

Inflammatory myofibroblastic tumors (IMTs) are particularly rare tumors that have been described in various anatomic locations, of which the urinary bladder is the most common. These benign tumors are amendable to conservative therapy but are notoriously difficult to diagnose given their mimicry of malignant sarcomas and sarcomatoid carcinomas, making an accurate diagnosis paramount to spare a patient radical and unnecessary treatment. We hereby present the case of a 37-year-old female patient who was diagnosed with an IMT of the urinary bladder during workup for painless gross hematuria. Patient was successfully managed with a laparoscopic partial cystectomy and is free of recurrence 5 years after surgery. IMTs are rare benign tumors that share the same clinical presentation as malignant bladder tumors. Deep biopsy and experienced pathologist are crucial in establishing diagnosis and avoiding patient radical treatment. This case is a classical demonstration of a remarkably rare tumor that was adequately managed with conservative therapy, achieving excellent clinical outcomes.

show abstract

Prolapsing inflammatory myofibroblastic tumor of the urinary bladder: A case report and a review of literature

Cited by 2 publications

References 5 publications

Clinicopathological Study of Oral Plasma Cell Granuloma

Clinicopathological Study of Oral Plasma Cell Granuloma

A Conservative Approach to Inflammatory Myofibroblastic Tumor of the Bladder: A Case Report and Review of Literature

Contact Info

Product

Resources

About